Gelatin in Life Science
Gelatin and its hydrolysate (collagen peptide) rank among the most versatile excipients used in bioscience. Acting as a hydrocolloid in various pharmaceutical and biomedical applications, gelatin’s benefits include its biocompatibility, biodegradability, plasticity, non-antigenicity, versatility and thermoreversible gel properties (Alipal et al., 2019).
Yet, despite its many advantages, standard-grade pharmaceutical gelatin naturally contains endotoxins. Particularly for parenteral applications, this can be problematic; endotoxins are pyrogens (fever-inducing substances) and, in high concentrations, can cause severe pathological effects, including septic shock, multiple organ failure and death.
As such, in pharmaceutical, medical device and healthcare environments, their control is crucial to ensure product safety and patient well-being. With MEDELLAPRO® and VACCIPRO®, GELITA offers specialized medical gelatins and collagen peptides that offer exceptionally high levels of purity, low allergenic potential, high tolerance by the body, low bioburden and an affinity for tissue cells.
What You’ll Learn in This E-Book:
- Why Low Endotoxin Levels Matter: Understand the clinical, research, and regulatory relevance of reducing pyrogens in biomedical applications.
- How MEDELLAPRO® and VACCIPRO® Deliver Added Value: Explore their specific roles in injectable formulations, drug delivery, bioprinting, scaffolds, wound care, and vaccine stabilization.
- Testing, Regulation, and Future Innovation: Learn how GELITA’s rigorous testing methods, pharma-grade documentation, and biotech innovations prepare you for tomorrow’s needs.